Toxicology - OPEN Foundation

Transformative Psychopharmacology: the Case of 5-Methoxy-N,N-Dimethyltryptamine

Jan M Keppel Hesselink | International Journal of Psychotherapy Practice and Research | 2 January 2019

DARK Classics in Chemical Neuroscience: Atropine, Scopolamine, and Other Anticholinergic Deliriant Hallucinogens

Lakstygal, A., Kolesnikova, T., Khatsko, S., Zabegalov, K., Volgin, A., Demin, K., & Kalueff, A. | ACS chemical neuroscience | 19 December 2018

Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions

Dinis-Oliveira, R. J., Pereira, C. L., & Da Silva, D. D | Current molecular pharmacology | 10 October 2018

Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions

Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018

Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine

Dunlap, L. E., Andrews, A. M., & Olson, D. E. | ACS chemical neuroscience | 12 July 2018

Cardiac arrest after ibogaine intoxication

Steinberg, C., & Deyell, M. W | Journal of arrhythmia | 12 June 2018

Key interindividual determinants in MDMA pharmacodynamics

Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018

Evaluating the abuse potential of psychedelic drugs for medical use in humans

Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018

Is LSD toxic?

Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017

First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects

Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of proteome research | 1 September 2017

MDA, MDMA and other mescaline-like substances in the US military’s search for a truth drug (1940s to 1960s)

Passie, T., & Benzenhöfer, U. | Drug testing and analysis | 29 August 2017

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs

Hassan, Z., Bosch, O. G., Singh, D., Narayanan, S., Kasinather, B. V., Seifritz, E., ... & Müller, C. P. | Frontiers in psychiatry | 18 August 2017

Mushroom-Derived Indole Alkaloids

Homer, J. A., & Sperry, J. | Journal of Natural Products | 19 July 2017

First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects

Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017

Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity

Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017

A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum

Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017

Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017

LSD instead of 25I-NBOMe: The revival of LSD? A case report

Bodeau, S., Bennis, Y., Régnaut, O., Fabresse, N., Richeval, C., Humbert, L., ... & Lemaire-Hurtel, A. S. | Toxicologie Analytique et Clinique | 27 February 2017

Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of internet purchased ibogaine

Henstra, M., Wong, L., Chahbouni, A., Swart, N., Allaart, C., & Sombogaard, F. | Clinical Toxicology | 9 February 2017

Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance

Dinis-Oliveira, R. J. | Drug Metabolism Reviews | 31 January 2017

Pharmacogenetics of ecstasy: CYP1A2, CYP2C19, and CYP2B6 polymorphisms moderate pharmacokinetics of MDMA in healthy subjects

Vizeli, P., Schmid, Y., Prestin, K., zu Schwabedissen, H. E. M., & Liechti, M. E. | European Neuropsychopharmacology | 20 January 2017